Literature DB >> 17177888

The indirect generation of long-distance structural changes in antibodies upon their binding to antigen.

Barbara Piekarska1, Anna Drozd, Leszek Konieczny, Marcin Król, Wiktor Jurkowski, Irena Roterman, Paweł Spólnik, Barbara Stopa, Janina Rybarska.   

Abstract

An allosteric mechanism for the generation of long-distance structural alterations in Fab fragments of antibodies in immune complexes has been postulated and tested in theoretical and experimental analysis. The flexing and/or torsion-derived forces exerted on the elbow region in Fab arms of bivalent antibodies upon binding to antigen were assumed to drive the disruption of hydrogen bonds which stabilize N- and C-terminal chain fragments in V-domains. This allows an extra movement in the elbow followed by a relaxation in the Fab arm and may generate long-distance effects if, in particular, the structural changes are generated asymmetrically involving one chain of the Fab arm only. This mechanism was studied by simulation of molecular dynamics. The local instability in the area involving the site of packing of the N-terminal chain fragment allows penetration and binding of the supramolecular dye Congo red that hence becomes an indicator of the initiated relaxation process and is also the prospective ligand in studies of designing drugs. The susceptibility to dye binding was observed in complexation of bivalent antibodies only, supplying the evidence that constraints associating the interaction with randomly distributed antigenic determinants drive the local structural changes in the V-domain followed by long-distance effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177888     DOI: 10.1111/j.1747-0285.2006.00448.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  8 in total

1.  Molecular evolution of affinity and flexibility in the immune system.

Authors:  Ian F Thorpe; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

2.  Revisiting the Immunoglobulin Intramolecular Signaling Hypothesis.

Authors:  Anthony Bowen; Arturo Casadevall
Journal:  Trends Immunol       Date:  2016-09-14       Impact factor: 16.687

Review 3.  The structural basis of antibody-antigen recognition.

Authors:  Inbal Sela-Culang; Vered Kunik; Yanay Ofran
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

4.  The use of supramolecular structures as protein ligands.

Authors:  Barbara Stopa; Anna Jagusiak; Leszek Konieczny; Barbara Piekarska; Janina Rybarska; Grzegorz Zemanek; Marcin Król; Piotr Piwowar; Irena Roterman
Journal:  J Mol Model       Date:  2013-01-08       Impact factor: 1.810

5.  Dispersion of single-wall carbon nanotubes with supramolecular Congo red - properties of the complexes and mechanism of the interaction.

Authors:  Anna Jagusiak; Barbara Piekarska; Tomasz Pańczyk; Małgorzata Jemioła-Rzemińska; Elżbieta Bielańska; Barbara Stopa; Grzegorz Zemanek; Janina Rybarska; Irena Roterman; Leszek Konieczny
Journal:  Beilstein J Nanotechnol       Date:  2017-03-16       Impact factor: 3.649

6.  Structural Analysis of Anti-Hapten Antibodies to Identify Long-Range Structural Movements Induced by Hapten Binding.

Authors:  Mohammed M Al Qaraghuli; Karina Kubiak-Ossowska; Valerie A Ferro; Paul A Mulheran
Journal:  Front Mol Biosci       Date:  2021-03-24

7.  Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.

Authors:  Nicole M Piche-Nicholas; Lindsay B Avery; Amy C King; Mania Kavosi; Mengmeng Wang; Denise M O'Hara; Lioudmila Tchistiakova; Madan Katragadda
Journal:  MAbs       Date:  2017-11-03       Impact factor: 5.857

8.  Interaction of Supramolecular Congo Red and Congo Red-Doxorubicin Complexes with Proteins for Drug Carrier Design.

Authors:  Anna Jagusiak; Katarzyna Chłopaś; Grzegorz Zemanek; Izabela Kościk; Irena Roterman
Journal:  Pharmaceutics       Date:  2021-11-28       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.